Editorial Archives - Page 94 of 122 - ExecEdge

Comera Life Sciences Boosts SQore Platform Patents

Comera Life Sciences Boosts SQore Platform Patents

By Daniella Parra Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), said it enhanced its SQore platform with four new patents and two notices of allowance. The additions, spanning the U.S., Canada, South Korea and India, will strengthen the proprietary viscosity-reducing...

Olaplex Sees New Opportunities After Lowering 2023 Guidance

Olaplex Sees New Opportunities After Lowering 2023 Guidance

By Daniella Parra Olaplex Holdings, Inc. (NASDAQ: OLPX) said it was looking forward to new investments and opportunities after reducing its fiscal 2023 outlook. Second quarter net sales were $109.2 million, down 48.2%; decreasing 58.7% in the U.S. and 34%...

FIGS Second Quarter Net Revenue Climbs 13%

FIGS Second Quarter Net Revenue Climbs 13%

By Daniella Parra FIGS, Inc. (NYSE: FIGS), the lifestyle brand dedicated to the healthcare community, said second quarter net revenue rose 13% to $138.1 million, driven by increases in orders and average order value. Active customers increased 21% to 2.5...

Input your search keywords and press Enter.